{"denomUnitsSelected":"Participants","description":"EQ-5D is a standardized participant-reported outcome measure developed by the EuroQol Group and used in this trial to assess health-related quality of life.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline to 16 weeks post-last-dose of study treatment (Dara, R, V or d)","title":"Health-related Quality of Life Assessment Changes From Baseline Using EuroQol Survey \"EQ-5D.\"","type":"SECONDARY"}